CDKN2B-AS1 and colorectal cancer: (2016) have reported that ANRIL knockdown significantly suppresses cell migration and invasion, tumor growth, and the capacity for lymphatic metastasis, suggesting that ANRIL is a potential curative target in colorectal cancer.